Institute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich, D-52425 Jülich, Germany.
Tandem Accelerator Facilities, INST, Atomic Energy Research Establishment, Savar, Dhaka 1000, Bangladesh.
Molecules. 2022 Jan 25;27(3):768. doi: 10.3390/molecules27030768.
The β-emitting radionuclide Y (t = 14.7 h) forms a matched-pair with the β-emitting therapeutic radionuclide Y (t = 2.7 d) for theranostic application in medicine. This approach demands a precise knowledge of the positron emission probability of the PET nuclide which was until recently rather uncertain for Y. In this work, an Y source of high radionuclidic purity was prepared and a direct measurement of the positron emission intensity per 100 decay of the parent (hereafter "positron emission intensity") was performed using high-resolution HPGe detector γ-ray spectroscopy. The electron capture intensity was also determined as an additional check by measuring the K and K X-rays of energies 14.1 and 15.8 keV, respectively, using a low energy HPGe detector. From those measurements, normalized values of 27.2 ± 2.0% for β-emission and 72.8 ± 2.0% for were obtained. These results are in excellent agreement with values recently reported in the literature based on a detailed decay scheme study.
β发射放射性核素 Y(t = 14.7 h)与β发射治疗放射性核素 Y(t = 2.7 d)形成配对,用于医学中的诊断和治疗应用。这种方法需要精确了解正电子发射概率的 PET 核素,而这在最近对于 Y 来说是相当不确定的。在这项工作中,制备了高放射性核纯度的 Y 源,并使用高分辨率 HPGe 探测器 γ 射线光谱直接测量母核的每 100 次衰变的正电子发射强度(此后称为“正电子发射强度”)。还通过使用低能 HPGe 探测器测量能量分别为 14.1 和 15.8 keV 的 K 和 K X 射线,确定了电子俘获强度作为附加检查。从这些测量中,得到了β发射的归一化值 27.2 ± 2.0%和 72.8 ± 2.0%。这些结果与最近基于详细衰变方案研究在文献中报告的值非常吻合。